Prevalence and predictors of depression in patients with systemic lupus erythematosus: A cross-sectional study

Neuropsychiatric Disease and Treatment

Volumn 9, Issue , 2013, Pages 799-804

  Maneeton, Benchalak ^a   Maneeton, Narong ^a   Louthrenoo, Worawit ^b  

^a Department of Psychiatry ^*  (Thailand)

^b CHIANG MAI UNIVERSITY   (Thailand)

Author keywords

Anxiety disorder; Depression; Systemic lupus erythematosus

Indexed keywords

ADULT; AGE; ANXIETY; ARTICLE; CONTROLLED STUDY; DEPRESSION; DISEASE ACTIVITY; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PATIENT ASSESSMENT; PREDICTION; PREVALENCE; RISK ASSESSMENT; RISK FACTOR; SCORING SYSTEM; SYSTEMIC LUPUS ERYTHEMATOSUS;

EID: 84878751007     PISSN: 11766328     EISSN: 11782021     Source Type: Journal    
DOI: 10.2147/NDT.S44248     Document Type: Article

References (39)

1. Waraich P, Goldner EM, Somers JM, Hsu L. Prevalence and incidence studies of mood disorders: a systematic review of the literature. Can J Psychiatry. 2004;49(2):124-138.
2. Jewett LR, Razykov I, Hudson M, Baron M, Thombs BD, on behalf of the Canadian Scleroderma Research G. Prevalence of current, 12-month and lifetime major depressive disorder among patients with systemic sclerosis. Rheumatology. 2013;52(4):669-675.
3. Maneeton B, Maneeton N, Mahathep P. Prevalence of depression and its correlations: a cross-sectional study in Thai cancer patients. Asian Pacific Journal of Cancer Prevention: APJCP. 2012;13(5):2039-2043.
4. Watson P, Storbeck J, Mattis P, Mackay M. Cognitive and emotional abnormalities in systemic lupus erythematosus: evidence for amygdala dysfunction. Neuropsychology review. 2012;22(3):252-270.
5. Gurevitz SL, Snyder JA, Wessel EK, Frey J, Williamson BA. Systemic lupus erythematosus: a review of the disease and treatment options. The Consultant pharmacist: the Journal of the American Society of Consultant Pharmacists. 2013;28(2):110-121.
6. Ainiala H, Loukkola J, Peltola J, Korpela M, Hietaharju A. The prevalence of neuropsychiatric syndromes in systemic lupus erythematosus. Neurology. 2001;57(3):496-500.
7. Jarpa E, Babul M, Calderon J, et al. Common mental disorders and psychological distress in systemic lupus erythematosus are not associated with disease activity. Lupus. 2011;20(1):58-66.
8. Hawro T, Krupinska-Kun M, Rabe-Jablonska J, et al. Psychiatric disorders in patients with systemic lupus erythematosus: association of anxiety disorder with shorter disease duration. Rheumatol Int. 2011;31(10):1387-1391.
9. Julian LJ, Gregorich SE, Tonner C, et al. Using the Center for Epidemiologic Studies Depression Scale to screen for depression in systemic lupus erythematosus. Arthritis Care Res (Hoboken). 2011;63(6):884-890.
10. Julian LJ, Tonner C, Yelin E, et al. Cardiovascular and disease-related predictors of depression in systemic lupus erythematosus. Arthritis Care Res (Hoboken). 2011;63(4):542-549.
11. Bachen EA, Chesney MA, Criswell LA. Prevalence of mood and anxiety disorders in women with systemic lupus erythematosus. Arthritis Rheum. 2009;61(6):822-829.
12. Iverson GL. Screening for depression in systemic lupus erythematosus with the British Columbia Major Depression Inventory. Psychol Rep. 2002;90(3 Pt 2):1091-1096.
13. Chin CN, Cheong I, Kong N. Psychiatric disorder in Malaysians with systemic lupus erythematosus. Lupus. 1993;2(5):329-332.
14. Zakeri Z, Shakiba M, Narouie B, Mladkova N, Ghasemi-Rad M, Khosravi A. Prevalence of depression and depressive symptoms in patients with systemic lupus erythematosus: Iranian experience. Rheumatol Int. 2012;32(5):1179-1187.
15. Iverson GL. Screening for depression in systemic lupus erythematosus with the British Columbia Major Depression Inventory. Psychol Rep. 2002;90(3 Pt 2):1091-1096.
16. Jump RL, Robinson ME, Armstrong AE, Barnes EV, Kilbourn KM, Richards HB. Fatigue in systemic lupus erythematosus: contributions of disease activity, pain, depression, and perceived social support. J Rheumatol. 2005;32(9):1699-1705.
17. Xie LF, Chen PL, Pan HF, et al. Prevalence and correlates of suicidal ideation in SLE inpatients: Chinese experience. Rheumatol Int. 2012; 32(9):2707-2714.
18. Maneeton B, Maneeton N, Louthrenoo W. Cognitive deficit in patients with systemic lupus erythematosus. Asian Pac J Allergy Immunol. 2010; 28(1):77-83.
19. Tan EM, Cohen AS, Fries JF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1982; 25(11):1271-1277.
20. Guzman J, Cardiel MH, Arce-Salinas A, Sanchez-Guerrero J, Alarcon-Segovia D. Measurement of disease activity in systemic lupus erythematosus. Prospective validation of 3 clinical indices. J Rheumatol. 1992;19(10):1551-1558.
21. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry. 1960;23:56-62.
22. Hamilton M. The assessment of anxiety states by rating. Br J Med Psychol. 1959;32(1):50-55.
23. Hamilton M. Development of a rating scale for primary depressive illness. Br J Soc Clin Psychol. 1967;6(4):278-296.
24. Brey RL, Holliday SL, Saklad AR, et al. Neuropsychiatric syndromes in lupus: prevalence using standardized definitions. Neurology. 2002; 58(8):1214-1220.
25. Hanly JG, McCurdy G, Fougere L, Douglas JA, Thompson K. Neuropsychiatric events in systemic lupus erythematosus: attribution and clinical significance. J Rheumatol. 2004;31(11):2156-2162.
26. Asano NM. Psychiatric disorders in patients with systemic lupus erythematosus. Arquivos de neuro-psiquiatria. 2013;71(3):200.
27. Meszaros ZS, Perl A, Faraone SV. Psychiatric symptoms in systemic lupus erythematosus: a systematic review. J Clin Psychiatry. 2012; 73(7):993-1001.
28. Nery FG, Borba EF, Viana VS, et al. Prevalence of depressive and anxiety disorders in systemic lupus erythematosus and their association with anti-ribosomal P antibodies. Prog Neuropsychopharmacol Biol Psychiatry. 2008;32(3):695-700.
29. Bachen EA, Chesney MA, Criswell LA. Prevalence of mood and anxiety disorders in women with systemic lupus erythematosus. Arthritis Rheum. 2009;61(6):822-829.
30. Shehata GA, Elserogy YM, Ahmad HE, et al. Multimodal neurophysiological and psychometric evaluation among patients with systemic lupus erythematosus. Int J Gen Med. 2011;4:325-332.
31. Lockefeer JP, De Vries J. What is the relationship between trait anxiety and depressive symptoms, fatigue, and low sleep quality following breast cancer surgery? Psychooncology. Epub June 13, 2012.
32. Xie J, Bi Q, Li W, et al. Positive and negative relationship between anxiety and depression of patients in pain: a bifactor model analysis. PloS one. 2012;7(10):e47577.
33. Delgado-Guay M, Parsons HA, Li Z, Palmer JL, Bruera E. Symptom distress in advanced cancer patients with anxiety and depression in the palliative care setting. Supportive Care in Cancer: Official Journal of the Multinational Association of Supportive Care in Cancer. 2009;17(5): 573-579.
34. Mak A, Tang CS, Chan MF, Cheak AA, Ho RC. Damage accrual, cumulative glucocorticoid dose and depression predict anxiety in patients with systemic lupus erythematosus. Clin Rheumatol. 2011; 30(6):795-803.
35. Sibbitt WL Jr, Brandt JR, Johnson CR, et al. The incidence and prevalence of neuropsychiatric syndromes in pediatric onset systemic lupus erythematosus. J Rheumatol. 2002;29(7):1536-1542.
36. Nery FG, Borba EF, Hatch JP, Soares JC, Bonfa E, Neto FL. Major depressive disorder and disease activity in systemic lupus erythematosus. Comprehensive psychiatry. 2007;48(1):14-19.
37. Lewis DA, Smith RE. Steroid-induced psychiatric syndromes. A report of 14 cases and a review of the literature. Journal of Affective Disorders. 1983;5(4):319-332.
38. Chiewthanakul P, Sawanyawisuth K, Foocharoen C, Tiamkao S. Clinical features and predictive factors in neuropsychiatric lupus. Asian Pac J Allergy Immunol. 2012;30(1):55-60.
39. Yancey CL, Doughty RA, Athreya BH. Central nervous system involvement in childhood systemic lupus erythematosus. Arthritis Rheum. 1981;24(11):1389-1395.